Outcome of second pregnancies when the first pregnancies were supported by metformin in patients of PCOS

International Congress Series

Volumn 1271, Issue C, 2004, Pages 46-49

  Malik, Sonia ^a   Katoch, Kavita ^a   Allahbadia, Gautam ^a  

^a Department of Obstetrics and Gynecology   (India)

Author keywords

Insulin resistance; Metformin; PCOS; Pregnancy

Indexed keywords

EID: 84964301525     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.07.001     Document Type: Article

References (11)

1. Glueck, C.J., et al. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 48 (1999), 1589–1595.
2. Glueck, C.J., et al. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss. Metabolism 52:12 (2003), 1627–1632.
3. Schachter, M., et al. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum. Reprod. 18:4 (2003 Apr.), 721–727.
4. Lanzone, A., et al. Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome. Hum. Reprod. 11 (1996), 2382–2386.
5. Glueck, C.J., et al. Continuing metformin throughout pregnancy in women with PCOS appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil. Steril. 75 (2001), 46–52.
6. Glueck, C.J., et al. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum. Reprod. 17 (2002), 2858–2864.
7. Jakubowicz, D.J., et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87 (2002), 524–529.
8. Paradisi, G., et al. Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. Hum. Reprod. 13 (1998), 542–546.
9. Coetzee, E.J., Jackson, W.P., Metformin in management of pregnant insulin-independent diabetics. Diabetologia 16 (1979), 241–245.
10. Nestler, J.E., Role of obesity and insulin in the development of anovulation. Filicori, M., Flamigni, C., (eds.) Ovulation Induction: Basic Science and Clinical Advances, 1994, Elsevier, Amsterdam, 103–114.
11. Glueck, C.J., et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum. Reprod. 19:3 (2004), 510–521.